← Open Payments lookup

CHRISTINE GUEBARA: Open Payments

NPI 1578513164 · GARDEN CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,047 in 11 payments from 8 companies in 2025. Trend: 2023 $115 · 2024 $130 · 2025 $2,047

Travel & lodging: $1,273Food & beverage: $774
CompanyPaymentsAmount
Neuronetics, Inc.3$1,867
Teva Pharmaceuticals USA, Inc.2$46
Otsuka America Pharmaceutical, Inc.1$25
Collegium Pharmaceutical, Inc.1$25
E.R. Squibb & Sons, L.L.C.1$23
Janssen Pharmaceuticals, Inc1$23
Axsome Therapeutics, Inc.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15

Products named: NEUROSTAR TMS THERAPY SYSTEM, UZEDY, ABILIFY MAINTENA, Jornay PM, COBENFY, SPRAVATO, Auvelity, CAPLYTA.

Industry payments across KS — which companies pay providers there.